SELECTIVE N-TYPE CALCIUM-CHANNEL ANTAGONIST OMEGA-CONOTOXIN MVIIA IS NEUROPROTECTIVE AGAINST HYPOXIC NEURODEGENERATION IN ORGANOTYPIC HIPPOCAMPAL-SLICE CULTURES
Ak. Pringle et al., SELECTIVE N-TYPE CALCIUM-CHANNEL ANTAGONIST OMEGA-CONOTOXIN MVIIA IS NEUROPROTECTIVE AGAINST HYPOXIC NEURODEGENERATION IN ORGANOTYPIC HIPPOCAMPAL-SLICE CULTURES, Stroke, 27(11), 1996, pp. 2124-2130
Background and Purpose Neuroprotection by antagonists of both L-type a
nd N-type calcium channels occurs in in vivo models of ischemia. The s
ite of action of calcium channel antagonists is unclear, however, and
it is likely that a combination of vascular and direct neuronal action
s occurs. We have investigated the effects of blocking neuronal calciu
m channels using an organotypic hippocampal-slice model of ischemia. M
ethods Organotypic hippocampal-slice cultures prepared from 10-day-old
rats were maintained in vitro for 14 days. Cultures were exposed to e
ither 3 hours of oxygen deprivation (hypoxia) or 1 hour of combined ox
ygen and glucose deprivation (ischemia). Neuronal damage was quantifie
d after 24 hours by propidium iodide fluorescence. Results Three hours
of anoxia produced damage exclusively in CA1 pyramidal cells. This da
mage was prevented by preincubation with omega conotoxin MVIIA, a sele
ctive N-type calcium channel blocker, and omega conotoxin MVIIC, which
blocks N-type and other presynaptic neuronal calcium channels. The di
hydropyridine nifedipine and the mixed calcium channel blocker SB20182
3-A were not protective. Furthermore, if addition of conotoxin MVIIA w
as delayed until after the hypoxic episode, a dose-dependent neuroprot
ective effect was observed, with an IC50 of 50 nmol/L. In contrast to
hypoxia, none of the compounds was neuroprotective in the model of oxy
gen-glucose deprivation, although it was determined that extracellular
calcium was essential for the generation of ischemic damage.Conclusio
ns These studies present clear evidence that neuroprotection by select
ive N-type calcium channel antagonists is mediated directly through ne
uronal calcium channels. In contrast, the neuroprotective effects of d
ihydropyridines may be mediated through vascular calcium channels or i
ndirectly through actions in other brain regions.